Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer.

Kalscheuer S, Khanna V, Kim H, Li S, Sachdev D, DeCarlo A, Yang D, Panyam J.

DOI: 10.1038/s41598-019-48993-6
Published: 2019-08-28
Container: Sci Rep
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-019-48993-6,
  title = {Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer.},
  author = {Kalscheuer S and  Khanna V and  Kim H and  Li S and  Sachdev D and  DeCarlo A and  Yang D and  Panyam J.},
  year = {2019},
  journal = {Sci Rep},
  doi = {10.1038/s41598-019-48993-6},
  url = {https://doi.org/10.1038/s41598-019-48993-6}
}

RIS

TY  - JOUR
TI  - Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer.
AU  - Kalscheuer S
AU  -  Khanna V
AU  -  Kim H
AU  -  Li S
AU  -  Sachdev D
AU  -  DeCarlo A
AU  -  Yang D
AU  -  Panyam J.
PY  - 2019
JO  - Sci Rep
DO  - 10.1038/s41598-019-48993-6
UR  - https://doi.org/10.1038/s41598-019-48993-6
ER  -

APA

S, K., V, K., H, K., S, L., D, S., A, D., D, Y., & J., P. (2019). Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer.. Sci Rep. https://doi.org/10.1038/s41598-019-48993-6

Source records

europe-pmc · retrieved 2026-09-26T22:43:55.150Z